| 5039 |
3 I strategy for TB-HIV |
30/04/2024 |
TB Comorbidities and special conditions |
| 262 |
Diabetes among people with TB |
03/05/2024 |
TB Comorbidities and special conditions |
| 6124 |
Health System |
07/05/2024 |
|
| 5875 |
Comparison between Health program and project |
07/05/2024 |
|
| 5873 |
A Health Program |
07/05/2024 |
|
| 6004 |
NTEP Training and Capacity Needs |
08/05/2024 |
|
| 6134 |
Multiple BCG vaccination Policy- Country wise profile |
13/05/2024 |
|
| 359 |
Development of Drug Resistance in MTB |
13/05/2024 |
DR-TB and PMDT |
| 6132 |
Indian studies on Adult BCG vaccination |
15/05/2024 |
|
| 6146 |
aBCG vaccine implementation study- Ethical Consideration |
15/05/2024 |
|
| 6145 |
aBCG vaccine implementation study- Preparatory Activities |
15/05/2024 |
|
| 6148 |
aBCG vaccine implementation study- Monitoring and Safety Evaluation Plan |
15/05/2024 |
|
| 6149 |
aBCG vaccine implementation study- Monitoring and Statistical Analysis Plan for Impact on TB Notification |
15/05/2024 |
|
| 6139 |
aBCG vaccine implementation study-Study methodology and objectives |
15/05/2024 |
|
| 6140 |
aBCG vaccine implementation study- Expected Study Outcomes |
15/05/2024 |
|
| 6141 |
aBCG vaccine implementation study- Study settings |
15/05/2024 |
|
| 6142 |
aBCG vaccine implementation study- Study Population: Inclusion Criteria |
15/05/2024 |
|
| 6143 |
aBCG vaccine implementation study-Study Population : Exclusion Criteria |
15/05/2024 |
|
| 6144 |
aBCG vaccine implementation study- Special consideration |
15/05/2024 |
|
| 6147 |
aBCG vaccine implementation study- Beneficiary Consent for Adult BCG Vaccination |
15/05/2024 |
|
| 6165 |
Duration of Vaccination session for aBCG vaccine implementation study |
15/05/2024 |
|
| 6170 |
Principles of Management following AEFI for aBCG vaccine implementation study |
15/05/2024 |
|
| 6169 |
Communication materials at session site for aBCG vaccine implementation study |
15/05/2024 |
|
| 6168 |
Session Arrangement for aBCG vaccine implementation study |
15/05/2024 |
|
| 6167 |
Flow of beneficiaries at vaccination session site for aBCG vaccine implementation study |
15/05/2024 |
|
| 6161 |
4 Key messages post aBCG vaccination session |
15/05/2024 |
|
| 6160 |
Difference between vaccination sites for aBCG vaccine implementation study and Routine immunization sites |
15/05/2024 |
|
| 6157 |
House marking for head-count survey for aBCG vaccine implementation study |
15/05/2024 |
|
| 6162 |
Wellness follow-up after aBCG Vaccination |
15/05/2024 |
|
| 6163 |
Human Resource Planning for aBCG vaccine implementation study |
15/05/2024 |
|
